China Jo-jo Drugstores Inc Institutional Investor Sentiment Worsened in Q1 2016

China Jo-jo Drugstores Inc institutional sentiment decreased to 0.75 in 2016 Q1. Its down -0.25, from 1 in 2015Q4. The ratio turned negative, as 3 hedge funds increased or opened new stock positions, while 4 reduced and sold holdings in China Jo-jo Drugstores Inc. The hedge funds in our partner’s database now possess: 148,237 shares, up from 123,312 shares in 2015Q4. Also, the number of hedge funds holding China Jo-jo Drugstores Inc in their top 10 stock positions was flat from 0 to 0 for the same number . Sold All: 2 Reduced: 2 Increased: 1 New Position: 2.

China Jo-Jo Drugstores, Inc. is a retailer and distributor of pharmaceutical and other healthcare products found in a retail pharmacy in the People’s Republic of China. The company has a market cap of $28.55 million. The Company’s operating divisions include retail drugstores, online pharmacy, wholesale business selling products similar to those the Company carries in its pharmacies, and farming and selling herbs used for traditional Chinese medicine . It has a 32.5 P/E ratio. The Firm has 59 store locations under the store brand Jiuzhou Grand Pharmacy in Hangzhou.

About 6,781 shares traded hands. China Jo-Jo Drugstores Inc has declined 14.29% since November 10, 2015 and is downtrending. It has underperformed by 14.11% the S&P500.

According to Zacks Investment Research, “China Jo-Jo Drugstores, Inc., through its contractually controlled affiliates, operates a retail pharmacy chain in China offering both western and traditional Chinese medicine. Its contractually controlled affiliates include Hangzhou Jiuzhou Grand Pharmacy Chain Co., Ltd., Hangzhou Jiuzhou Clinic of Integrated Traditional and Western Medicine General Partnership, and Hangzhou Jiuzhou Medical & Public Health Service Co., Ltd. The chain has stores throughout Hangzhou, the provincial capital of Zhejiang Province.”

California Public Employees Retirement System holds 0% of its portfolio in China Jo-Jo Drugstores Inc for 29,300 shares. Citadel Advisors Llc owns 25,965 shares or 0% of their US portfolio. Moreover, Citigroup Inc has 0% invested in the company for 434 shares. The New York-based Morgan Stanley has invested 0% in the stock. Renaissance Technologies Llc, a New York-based fund reported 79,800 shares.